VBIO
Financials
- Market Capitalization 2.66 M
- Employee 52
- Founded 2016
- CEO N/A
- Website www.tivichealth.com
- Headquarter Delaware, United States
- FIGI BBG00PT2YC04
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4966 |  VIVS VivoSim Labs, Inc. - Common Stock | 0.29 USD | 0.00% | +3.57% | -14.71% | -84.82% | 4.31 M USD | ||
| 5018 |  PPCB Propanc Biopharma, Inc. - Common Stock | 1.35 USD | -39.46% | +19.47% | +35.00% | -54.85% | 3.08 M USD | ||
| 5066 |  DCOY Decoy Therapeutics Inc. - Common Stock | 2.90 USD | -2.36% | -9.94% | -30.46% | +258.56% | 1.90 M USD | ||
| 5229 |  AZN AstraZeneca PLC - American Depositary Shares | 162.70 USD | -1.10% | -1.14% | -4.47% | +103.73% | 0 USD |
Frequently asked questions about Valion Bio, Inc. Common Stock
What is the Valion Bio, Inc. Common Stock stock price today?
The current price of Valion Bio, Inc. Common Stock (VBIO) is 0.12. Over the past 24 hours, the stock has changed by 0.00%. Follow the VBIO chart for real-time price dynamics.
What is the stock ticker of Valion Bio, Inc. Common Stock?
Valion Bio, Inc. Common Stock trades under the ticker VBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Valion Bio, Inc. Common Stock stock going up?
VBIO has changed by -14.29% over the last week, -55.56% over the last month, and -90.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Valion Bio, Inc. Common Stock?
Valion Bio, Inc. Common Stock currently has a market capitalization of 2.66 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Valion Bio, Inc. Common Stock earnings last quarter?
Last quarter, Valion Bio, Inc. Common Stock reported earnings of -2.17 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Valion Bio, Inc. Common Stock revenue for the last quarter?
Valion Bio, Inc. Common Stock reported quarterly revenue of 47 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Valion Bio, Inc. Common Stock net income for the last quarter?
Valion Bio, Inc. Common Stock reported net income of -7.1 M for the last quarter. The previous quarter showed -6.2 M, which means net income changed by -14.53%.
How many employees does Valion Bio, Inc. Common Stock have?
As of the latest available data, Valion Bio, Inc. Common Stock has 52 employees. Workforce size can provide additional context about the company's scale and operations.
What is Valion Bio, Inc. Common Stock EBITDA?
Valion Bio, Inc. Common Stock EBITDA is -5.53 M, and its EBITDA margin is -11.77 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Valion Bio, Inc. Common Stock stock?
You can buy Valion Bio, Inc. Common Stock (VBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Valion Bio, Inc. Common Stock stock?
Investing in Valion Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VBIO chart and related analysis on metatrader.com as part of your research.